KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
2021 · Kidney International · 1,317 citations
https://doi.org/10.1016/j.kint.2020.11.003
R
Roberto Pecoits‐Filho
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
744
Papers
27.5K
Citations
78
h-index
326
i10-index
Roberto Pecoits‐Filho is an academic researcher from Pontifícia Universidade Católica do Paraná. The author has contributed to research in topics: Dialysis and Renal Disease Management & Chronic Kidney Disease and Diabetes & Blood Pressure and Hypertension Studies. The author has an h-index of 78, co-authored 633 publications.
ORCID: 0000-0002-0255-6710Papers by this author
worksGlobal kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
2017 · The Lancet · 895 citations
https://doi.org/10.1016/s0140-6736(17)30788-2
Chronic Kidney Disease and Coronary Artery Disease
2019 · Journal of the American College of Cardiology · 662 citations
https://doi.org/10.1016/j.jacc.2019.08.1017
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
2016 · Kidney International · 468 citations
https://doi.org/10.1016/j.kint.2015.10.002
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
2021 · Kidney International · 369 citations
https://doi.org/10.1016/j.kint.2021.03.033
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
2021 · Kidney International · 316 citations
https://doi.org/10.1016/j.kint.2020.10.026
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat